Maybe that's why the share price isn't being impacted by the lack of Ropren approval - Bioeffective A is outperforming all on its own.
I predict Solagran will merge with Neptune Marine Services to create a Bioeffective pipeline between Russia and the United States. The result will surely be the world's first trillion-dollar company.
Buy now before it's too late.